News & Stories

Time is critical for patients with rare diseases like hemophilia A, a genetic bleeding disorder that affects an estimated 1 in 4,000-5,000 male births. BioMarin’s newest gene therapy has the promise of delivering, in as little as a single administration, the missing gene needed to produce factor VIII (the clotting factor deficient in hemophilia A patients). Pall helped produce the drug using the power of single use technology, which compared to traditional stainless steel factories, helped cut BioMarin’s customers’ time to market by half—and meant that therapy solutions could hit the market earlier, giving patients relief.

This October, Leica Biosystems Tissue Acquisition Solutions team members around the world were busy promoting the importance of Breast Cancer Awareness month and raising funds for multiple breast cancer charities. Headquartered in Cincinnati, Ohio, the company is committed to advancing technology for the early detection of breast cancer, providing support and education for clinicians worldwide, and offering breast care information for patients.

The primary purpose of the packaging value chain is to add value to a product by making it more desirable to customers through the packaging, branding/marketing and sales enablement. The Product Identification Platform of companies are strategically aligned to simplify this process for our customers offering an unparalleled level of expertise in the packaging value chain.

Danaher received a perfect score of 100% on the 2018 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to lesbian, gay, bisexual, transgender and queer (LGBTQ) workplace equality, administered by the Human Rights Campaign (HRC) Foundation.  Danaher joins the ranks of many major U.S. businesses which also earned top marks this year.

The Leica Biosystems site in Melbourne, Australia held a Science Expo that was open to all associates and their families. Leica Biosystems Melbourne specializes in producing some of the world's best cancer diagnostic instrumentation and this was the first time they ran an event specifically for showcasing their role in the Anatomical Pathology workflow. More than 220 associates and their families attended patient scenario simulations conducted by Leica's in-house scientists.